a total of 13 145 subjects were screened: 4508 first-degree and 1275 second-degree relatives of patients with biopsy-proven cd, 3236 symptomatic patients (with either gastrointestinal symptoms or a disorder associated with cd), and 4126 not-at-risk individuals.